Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
EpiCor + vitamin C
- Development stage
- Unknown
- Lead developer
- Embria
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Small Molecules, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
EpiCor + vitamin C is a dietary supplement combination designed to support immune system health and gut microbiome balance. EpiCor is a branded postbiotic ingredient, specifically a whole food fermentate derived from *Saccharomyces cerevisiae* (baker's yeast) through a proprietary fermentation process. This process preserves a complex matrix of bioactive compounds, including beta-glucans, polyphenols, vitamins, amino acids, and metabolites. EpiCor functions by modulating immune responses and acting as a prebiotic to support beneficial gut bacteria. Vitamin C (ascorbic acid) is included for its well-established antioxidant properties and its role in supporting various cellular functions of both the innate and adaptive immune systems. The combination is primarily marketed to reduce the incidence and severity of cold and flu symptoms and to manage nasal congestion associated with seasonal allergies.
- Brand names
- EpiCor Plus Immunity
- Other names
- EpiCor + Vitamin Cdried yeast fermentate + vitamin CSaccharomyces cerevisiae fermentate + ascorbic acid
Beyond the preview
Go deeper on EpiCor + vitamin C.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on EpiCor + vitamin C.